Associate Director, Corporate Communications at Tarsus Pharamceuticals

Irvine, California, United States

Tarsus Pharamceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Bachelor’s degree in Communications, Public Relations, Journalism, or a related field
  • Minimum of 12 years of relevant experience, with 10 years in Corporate Communications, and at least 5–7 years supporting executive-level communications
  • Prior experience in the pharmaceutical or life sciences industry strongly preferred
  • Strong knowledge of compliance considerations and experience working within regulated environments
  • Exceptional writing, editing, and storytelling skills with meticulous attention to detail
  • Demonstrated experience with media relations, corporate announcements, and issues management
  • Proven ability to distill complex scientific and business data into clear, digestible narratives for diverse audiences
  • Proven ability to collaborate with and counsel senior leadership
  • Proficient in managing external communications agencies and associated budgets
  • Strategic thinker with a collaborative mindset and a high level of discretion, sound judgment, and cultural sensitivity

Responsibilities

  • Develop and execute strategic communication plans that support corporate, executive, and pipeline communications goals
  • Create compelling content for corporate brand and executive platforms, including company narratives, executive talking points, social media posts, op-eds, and presentations
  • Draft and support external announcements, including press releases, media Q&As, messaging documents, and briefing materials
  • Proactively identify and manage executive visibility opportunities, including speaking engagements and award submissions
  • Manage corporate sponsorships, partnerships, and charitable contribution programs aligned with company values
  • Oversee and collaborate with external communications agencies to deliver impactful, high-quality work
  • Partner closely with teams across Corporate Affairs, Investor Relations, HR, Legal, and other departments to ensure cohesive and aligned messaging
  • Contribute to the effective management of communications budgets and agency resources

Skills

Strategic Communications
Content Creation
Press Releases
Media Q&As
Social Media
Op-Eds
Presentations
Executive Visibility
Speaking Engagements
Agency Management
Cross-functional Collaboration

Tarsus Pharamceuticals

Develops treatments for eye care diseases

About Tarsus Pharamceuticals

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company is also working on other potential treatments for conditions such as Lyme Disease Prevention, Meibomian Gland Disease, and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong pipeline of future products. Their goal is to provide effective treatments for patients suffering from these conditions while ensuring compliance with regulations and ethical standards.

Irvine, CaliforniaHeadquarters
2017Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in ophthalmic treatments challenges Tarsus's market position.
Potential clinical trial delays could affect Tarsus's product pipeline.
Supply chain constraints may hinder XDEMVY's production and distribution.

Differentiation

Tarsus focuses on high unmet needs in ophthalmic and infectious diseases.
Their lead product, XDEMVY, is FDA-approved for Demodex blepharitis treatment.
Tarsus's pipeline includes innovative treatments for Lyme disease and Rosacea.

Upsides

Growing awareness of Demodex blepharitis expands market for Tarsus's XDEMVY.
Telemedicine rise offers new marketing opportunities for Tarsus's products.
FDA's focus on unmet needs may expedite Tarsus's pipeline approvals.

Land your dream remote job 3x faster with AI